Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and Vaccination
Description
BACKGROUND: SARS-CoV-2 variants continue to circulate globally, even within highly vaccinated populations. The first-generation SARS-CoV-2 vaccines elicit neutralizing immunoglobin G (IgG) antibodies that prevent severe COVID-19 but induce only weak
